Company Search:
Advanced Search
Sponsored Links
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tissue Regenix Group PLC with three other companies in this sector in UNITED KINGDOM : MaxCyte Inc (2019 sales of £16.90 million [US$22.57 million] of which 100% was Medical Service), Yourgene Health PLC (£8.88 million [US$11.86 million] of which 100% was Molecular diagnostics business), and Bioventix Plc (£9.29 million [US$12.40 million] ).

Sales Analysis. During the year ended December of 2019, sales at Tissue Regenix Group PLC were £13.03 million (US$17.40 million). This is an increase of 12.2% versus 2018, when the company's sales were £11.62 million. This was the fifth consecutive year of sales increases at Tissue Regenix Group PLC (and since 2014, sales have increased a total of 217,117%). Sales of Biosurgery saw an increase that was more than double the company's growth rate: sales were up 25.2% in 2019, from £3.38 million to £4.23 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): .42p
(Figures in Pounds Sterling)
1 Week 2.4%   13 Weeks 13.5%  
4 Weeks 27.3%   52 Weeks -71.2%  
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 13,033,000
(Year Ending Jan 2020).
Employees: 99
  Currency: Pounds Sterling Market Cap: 29,538,540
  Fiscal Yr Ends: December Shares Outstanding: 7,032,985,756
  Share Type: Ordinary Closely Held Shares: 1,295,725,811
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.